Charles Schwab Investment Management Inc An2 Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $527 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$7.94 - $15.6 $39,700 - $78,000
5,000 Added 20.08%
29,898 $295,000
Q4 2022

Feb 13, 2023
BUY
$8.51 - $19.69 $125,173 - $289,620
14,709 Added 144.36%
24,898 $237,000
Q2 2022

Aug 15, 2022
BUY
$7.7 - $18.82 $78,455 - $191,756
10,189 New
10,189 $79,000

Others Institutions Holding ANTX

# of Institutions
38
Shares Held
13.8M
Call Options Held
0
Put Options Held
0
View Full List

About AN2 Therapeutics, Inc.

ANTX Quotes by TradingView
  • Ticker ANTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,402,700
  • Market Cap $21.9M
  • Description
  • AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...
More about ANTX
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email